Related Experiment Video
Updated: Apr 15, 2026

07:51
Effects of Allogeneic Platelet-Rich Plasma PRP on the Healing Process of Sectioned Achilles Tendons of Rats: A Methodological Description
Published on: March 19, 2018
9.8K
[Chronic tendinopathies and platelet-rich plasma]
Revue Medicale De Liege
|March 24, 2015
Summary
Platelet-Rich Plasma (PRP) contains growth factors that aid healing. This research assessed PRP
Area of Science:
- Biomedical Science
- Regenerative Medicine
- Orthopedics
Background:
- Platelets are crucial components of blood, containing numerous growth factors.
- Upon activation and degranulation, platelets release these factors, initiating tissue repair processes.
- The clinical efficacy of Platelet-Rich Plasma (PRP) therapy remains a subject of ongoing scientific debate.
Purpose of the Study:
- To evaluate the therapeutic effectiveness of Platelet-Rich Plasma (PRP) in promoting tendon healing.
- To investigate the clinical outcomes of PRP treatment for chronic jumper's knee in human patients.
Main Methods:
- Utilized animal models to study tendon healing following PRP application.
- Conducted clinical assessments on human subjects diagnosed with chronic jumper's knee undergoing PRP therapy.
- Measured healing indicators and patient-reported outcomes.
Main Results:
- Observed positive effects of PRP on the healing of animal tendons.
- Demonstrated potential benefits of PRP in managing chronic jumper's knee symptoms.
- Results contribute to the understanding of PRP's clinical utility.
Conclusions:
- Platelet-Rich Plasma (PRP) shows promise in enhancing tendon repair.
- PRP may offer a viable treatment option for chronic jumper's knee.
- Further research is warranted to solidify PRP's role in clinical practice.
Related Concept Videos
Formation of the Platelet Plug
11.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
11.0K
Peripheral Artery Disease III: Interprofessional Care
623
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
623
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Structure and Function of Platelets
6.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.6K

